The effect of IFNβ-1b on the evolution of enhancing lesions in secondary progressive MS

Abstract

IFNbeta-1b reduced the number of new enhancing lesions, with a greater effect on small lesions. However, when a new enhancing lesion did become established, treatment with IFNbeta-1b did not alter its subsequent course.